Teladoc Health (TDOC)
(Delayed Data from NYSE)
$12.73 USD
-0.17 (-1.32%)
Updated May 17, 2024 04:00 PM ET
After-Market: $12.74 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.73 USD
-0.17 (-1.32%)
Updated May 17, 2024 04:00 PM ET
After-Market: $12.74 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
Teladoc Health, Inc. (TDOC) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Teladoc Health, Inc. (TDOC).
Is Teladoc Health (TDOC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TDOC) Outperforming Other Medical Stocks This Year?
Healthcare ETF (IHF) Tops in October: 5 Best Stocks
by Sweta Killa
Inside the best performing stocks of the top ETF of October.
Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Teladoc (TDOC) Q3 earning are likely to have benefited from increased membership and visits, and accretive effect of earlier acquisitions.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks & ETF to Invest in Healthcare Robotics and Innovation
by Neena Mishra
HTEC is poised to benefit from rapid advances in health-care technology
Should Teladoc Worry About Amazon's Virtual Healthcare Move?
by Zacks Equity Research
Teladoc (TDOC) might face increasing competition from Amazon in virtual healthcare space once the latter expands its presence.
Stocks & ETF to Invest in Healthcare Robotics and Innovation
by Neena Mishra
HTEC is poised to benefit from rapid advances in health-care technology.
Teladoc Gains on Growing Acceptance for TeleHealth Services
by Zacks Equity Research
Teladoc's (TDOC) extensive ecosystem and infrastructure poise it well for long-term growth in the expanding telehealth industry.
Teladoc Up 33% Year to Date: Will the Momentum Continue?
by Zacks Equity Research
Teladoc's (TDOC) vast business presence in the growing telehealth industry with many deal wins and international expansion should drive long-term growth.
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of -2.50% and 0.46%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Stock Q2 Earnings Due on Jul 31: HUM, AMED & More
by Zacks Equity Research
Healthcare stocks like HUM, AMED, CRL, TDOC and PRAH are likely to benefit from higher membership and revenues in the second quarter.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Up 22% in a Year: Will the Rally Continue?
by Zacks Equity Research
Teladoc's increasing visits and subscriptions are likely to aid revenue growth. This will further drive its share price.
Why Should You Retain Teladoc (TDOC) in Your Portfolio?
by Zacks Equity Research
Banking on improving revenues and strategic acquisitions, Teladoc (TDOC) holds great potential to garner benefits for investors.
Teladoc (TDOC) Up 0.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Health (TDOC) Surpasses Estimates in Q1 Earnings
by Zacks Equity Research
Teladoc's (TDOC) loss in the first quarter can be attributed to higher operating expenses than revenues.
Teladoc (TDOC) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Teladoc's (TDOC) Q1 earnings should benefit from increase in revenues, partly offset by rise in expenses.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc's Partnership to Form Pediatric Telehealth Platform
by Zacks Equity Research
Teladoc (TDOC) teams up with Cincinnati Children's Hospital Medical Center to launch consumer pediatric telehealth platform.
Why Is Teladoc (TDOC) Down 16.6% Since Last Earnings Report?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc (TDOC) Introduces Telemedicine Services in Canada
by Zacks Equity Research
Teladoc (TDOC) introduces Teladoc Telemedicine Services for Canadians. The new offering will enable them to enjoy convenient healthcare services.
Teladoc to Acquire MedecinDirect, Expand Overseas Business
by Zacks Equity Research
Teladoc's (TDOC) acquisition of MedecinDirect will aid it in enhancing presence in expanding virtual care market in France.
Teladoc (TDOC) Q4 Earnings Meet Estimates, Revenues Beat
by Zacks Equity Research
Teladoc (TDOC) reports lower losses supported by an increase in revenues partly offset by a rise in expenses.
What's in Store for Teladoc's (TDOC) Q4 Earnings?
by Zacks Equity Research
Teladoc's (TDOC) Q4 earnings might suffer high expenses, partly offset by rise in revenues.